Representative Maria Elvira Salazar (R-Fla.) has disclosed a series of stock transactions from August, according to a report from Benzinga. The filings detail multiple purchases and sales across various sectors, including technology, healthcare, and consumer goods.
The transactions included the purchase of shares in Space Exploration Technologies Corp (NASDAQ: SPCX). On August 12, Salazar disclosed buying between $1,000 and $15,000 in SpaceX stock on two separate occasions. At the time of the purchase, shares of the company were trading between $134.01 and $149.60. The article notes that the stock was trading at $148.18 at the time of the report.
Salazar also disclosed buying shares of Berkshire Hathaway B (NYSE: BRK) on August 7, with an investment valued between $1,000 and $15,000. This purchase follows previous buying activity in July, where she purchased shares in Berkshire Hathaway in two separate transactions, one valued between $1,000 and $15,000 and another between $15,000 and $50,000.
On August 19, the congresswoman purchased shares of Merck & Co. Inc (NYSE: MRK). She also bought and sold shares of Moderna Inc (NASDAQ: MRNA) on the same day. Moderna announced news regarding a successful Phase 3 melanoma cancer vaccine that uses Merck’s Keytruda on that date. Moderna shares were highly volatile on August 19, trading in a range of $114.46 to $176.66.
According to data from Quiver Quantitative, Salazar has made over 120 trades since 2022, totaling $8.67 million. The report notes that she made zero transactions in 2025. As of the report, she is already over $1.55 million in trades for 2026, with $1.33 million in purchases and $218,000 in sales.
